2012
DOI: 10.1016/j.arth.2012.03.040
|View full text |Cite
|
Sign up to set email alerts
|

Is it Time to Include Vancomycin for Routine Perioperative Antibiotic Prophylaxis in Total Joint Arthroplasty Patients?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
53
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 69 publications
(54 citation statements)
references
References 22 publications
1
53
0
Order By: Relevance
“…Many prior studies have compared vancomycin with cephalosporins and have demonstrated conflicting results [11][12][13]16]. These studies are rarely focused on the blactam-allergic population and frequently represent the outcomes of universally administering vancomycin.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Many prior studies have compared vancomycin with cephalosporins and have demonstrated conflicting results [11][12][13]16]. These studies are rarely focused on the blactam-allergic population and frequently represent the outcomes of universally administering vancomycin.…”
Section: Discussionmentioning
confidence: 99%
“…These studies are rarely focused on the blactam-allergic population and frequently represent the outcomes of universally administering vancomycin. In a series of 5,036 primary TJAs, Smith et al [13] found that transitioning from cefazolin to vancomycin resulted in a significant reduction of PJI from 1% to 0.5% [13]. Tyllianakis et al [16] demonstrated no difference (six of 188 versus six of 120) in the SSI or PJI rate between those receiving cefuroxime and vancomycin in a prospective randomized trial in nonpenicillin-allergic patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been suggested that in some settings, particularly those in which the local antibiogram includes a high proportion of infections with methicillin-resistant Staphyloccus aureus (MRSA), vancomycin may be appropriate for prophylactic antibiotic regimens [1,7]. However, researchers have observed complications in patients with routine administration of vancomycin including resistant bacteria, acute kidney injury, and hearing loss.…”
mentioning
confidence: 99%
“…Moreover, Vancomycin needs to be combined with traditional prophylactic agents in order to provide coverage against Gram-negative bacteria. The benefits to adding vancomycin to prophylactic regimens is still hotly debated [5][6][7].…”
mentioning
confidence: 99%